A LASSO-derived model for the prediction of nonattainment of target LDL-C reduction with PCSK9 inhibitors in patients with atherosclerotic cardiovascular disease
This study presents a LASSO-derived predictive model that can be used to predict the risk of NTR-LDLC with PCSK9 inhibitors in patients with ASCVD.
Authors
- Xiaodong Sun (ORCID: https://orcid.org/0000-0001-5015-0945)
- Mengdi Zhang (ORCID: https://orcid.org/0009-0007-8207-7093)
- Wenxing Peng (ORCID: https://orcid.org/0000-0001-7653-4672)
- Yang Lin (ORCID: https://orcid.org/0009-0000-2552-6840)
- Xiao‐Chun Duan (ORCID: https://orcid.org/0009-0002-1055-988X)
Institutions
- Capital Medical University (CN)
- Beijing Anzhen Hospital (CN)
Publication Details
- Journal
- Lipids in Health and Disease
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1186/s12944-025-02488-8
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Chinese Pharmaceutical Association